Kras g12c small molecule inhibitor
The KRAS G12C small molecule inhibitor is a laboratory reagent designed to target the KRAS G12C mutation, a common oncogenic driver in various cancer types. It functions by inhibiting the activity of the KRAS G12C protein, which plays a crucial role in cellular signaling and proliferation. This product is intended for research use only and should not be used for any other purpose.
2 protocols using kras g12c small molecule inhibitor
KRAS G12C Inhibitor Treatment Effects
KRAS G12C Inhibition in Lung Cancer
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!